The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.
This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.
Claudio Maffeis graduated in Medicine in 1985, at the University of Verona (Italy). He post graduated in Pediatrics in the same University in 1989 and in Gastroenterology in 1999. He spent his postdoctoral training with a residency at the Institute of Paediatrics, University of Verona and, in part, at the Institute of Physiology, University of Lausanne (CH). In 1993 he was research fellow at the Department of Paediatrics, Tufts University, Boston MA (USA).
He made his clinical and academicals career at the Institute of Pediatrics, University of Verona: Assistant Professor (1989), Consultant (1994), Associate Professor of Pediatrics (2004), Full Professor of Pediatrics (2016-).
He is the director of the Pediatric B (2010-) and the Regional Center for Pediatric Diabetes (2010-) at the Mother & Child Hospital of Verona.
He is a member of some international (ISPAD, EASO), and national scientific societies [Italian Society of Pediatric Endocrinology and Diabetology (ISPED), Italian Society of Pediatrics (ISP) and the Italian Society of Obesity (ISO)]; he served as advisor in ISPED and ISO. He had the chair of the Childhood Obesity Research Group of the ISPED, he served as the Vice-President of the European Childhood Obesity Group and the President of the ISPED (2019-2021).
He actively participated to several Congresses, both national and international, giving lectures or presenting oral communications. In 1987, 1992 and 1995 he received national and international awards for his research.
His main research interests are diabetes, obesity, and nutrition in children and adolescents. More than 300 scientific articles published in national and international journals are the result of his work (Scopus access 27.07.2022: HI: 42, citations: 7,313). He was the principal investigator of most of the research he participated in. Several International Journals published the results of his studies: Nature, Journal of Clinical Endocrinology and Metabolism, International Journal of Obesity, Obesity, Pediatric Obesity, Diabetologia, Diabetes Research and Clinical Practice, Pediatric Diabetes, Pediatrics, Journal of Paediatrics, American Journal of Clinical Nutrition, Nutrition Metabolism and Cardiovascular Diseases, European Journal of Clinical Nutrition, etc.
He is Deputy Editor of the European Journal of Clinica Nutrition (2021-) and Associate Editor of the British Journal of Nutrition (2020-) and the Italian Journal of Pediatrics (2020-)
Aaron Kelly
University of Minnesota Medical School , Minneapolis, MN, USA
Dr. Kelly is a Professor of Pediatrics, the Minnesota American Legion and Auxiliary Chair in Children’s Health, and the Co-Director of the Center for Pediatric Obesity Medicine at the University of Minnesota Medical School. He has over 20 years of experience conducting clinical trials for the treatment of pediatric obesity and has published over 100 peer-reviewed papers on related topics. Dr. Kelly’s NIH-funded research program focuses primarily on obesity pharmacotherapy but extends to all types of weight management interventions. His work also seeks to identify and characterize predictors of treatment response to advance the discipline of precision obesity medicine and improve care delivery for children and adolescents with obesity. Dr. Kelly is actively involved in numerous initiatives related to pediatric obesity treatment in the United States and internationally, has held various leadership positions in The Obesity Society and American Heart Association, and is a Fellow of both organizations.
Abdullah Bereket
University of Istanbul, Istanbul, Turkey
Prof. Bereket has graduated from Ankara University, Medical School in 1986. After finishing pediatric residency training in 1991, he completed his fellowship in Pediatric Endocrinology at State University of New York at Stony Brook, USA in 1991-1996. He was appointed as Assistant Professor at Hacettepe University of Ankara in 1997. In 1999, he founded Pediatric Endocrinology division at Marmara University of Istanbul and is currently chief of the division and subspecialty training program. He was granted full professorship in 2003. Dr Bereket authored more than 160 peer-reviewed articles in international journals. He was awarded as outstanding young scientist by Turkish Academy of Sciences in 2001. He is a member of European Society for Pediatric Endocrinology (ESPE) and served in board of ESPE Bone Club and ESPE Summer school steering commitee in 2011-2015. He has served as, treasurer, vice president and President of Turkish Pediatric Endocrin Society between 2001-2007. He is associate editor of Journal of Clinical Research in Pediatric Endocrinology, Journal of Pediatric Endocrinology and Metabolism and in the editorial board of Hormone Research in Pediatrics. His main research interests are insulin-like growth factors, obesity, precocious puberty, and rickets.
Bassam Bin Abbas
King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
Dr. Bassam Saleh Bin-Abbas is a Consultant in the Section of Endocrinology and Diabetes, Department of Pediatrics at King Faisal Specialist Hospital and Research Center in Riyadh, Saudi Arabia. He is also a Professor of Pediatrics and Endocrinology at the Al-Faisal University. In the USA, he obtained certification at the American Board of Pediatrics after completing his residency program at Yale University in 1997 and American Board of Pediatric Endocrinology after his fellowship training at UCSF/Stanford University in 1999.
Jason Halford
University of Leeds, Leeds, UK
Jason Halford is Head of the School of Psychology at the University of Leeds, President of the European Association of Obesity (EASO), and former Chair of the UK Association for the Study of Obesity (ASO). He is a Chartered Health Psychologist. Over the past 10 years his research has focused on drug-induced weight gain, the effects of nutrients and fibre on appetite and hormone release, the effects of stress on eating behaviour, the effect of marketing on children, and on lean-obese differences in the expression of appetite. In 1999, Jason co-founded the Human Ingestive Behaviour Laboratory at Liverpool and in 2004 he also co-founded the Liverpool Obesity Research Network (LORN). Jason is co-ordinator of the SWITCH study, a new trial to examine the impact of artificial sweeteners on appetite in the context of active weight management and is one of the co-ordinating leads for the 9m Euro H2020 SWEET project designed to examine the risks and benefits of using sweeteners to replace sugar in the diet in the contexts of health, obesity, safety and sustainability. Jason is also local lead for iKnowFood. Additionally, he is a Board member of the European Coalition of People Living with Obesity (ECPO) and is also the Lead of the ACTION-Teens Study which looks at the experiences of adolescents living with obesity globally.